NSETrading Window28 Sept 2026 · 28 Sept 2026, 10:22 am

Trading Window

GPT Healthcare Limited · GPTHEALTH

✦ AI SummaryResults

GPT Healthcare Limited has closed its trading window for insiders due to the upcoming announcement of its 2nd quarter and half-year financial results.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

GPT Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

GPTHEALTHCARE_28092026102150_GHL-Trading_Window_Closure_September_2026.pdf

pdf

Download →
View document text
GPT Healthcare Limited Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402 Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in GPTHEALTH/CS/SE/2026-27 September 28, 2026 The Department of Corporate Services National Stock Exchange of India Limited BSE Limited, Exchange Plaza, Plot no. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (E), Dalal Street Mumbai - 400 051 Mumbai – 400001 Scrip Symbol: GPTHEALTH Scrip Code: 544131 ISIN: INE486R01017 Dear Sir/Madam Sub: Intimation of Closure of Trading Window. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended) and the Company’s Code of Conduct to regulate, monitor and report trading by designated persons, the trading window for dealing in the securities of the Company by the Designated Persons and their immediate relatives shall remain closed from Thursday, October 01, 2026 till 48 (forty- eight) hours after the declaration of the Un-Audited Financial Results of the Company for the 2nd quarter and half year ending on September 30, 2026. The date of the Board meeting of the Company for consideration and approval of the Un-Audited Financial Results for the 2nd quarter and half year ending on September 30, 2026 will be intimated in due course. Accordingly, all the Designated Persons of the Company and their immediate relatives are advised not to trade in the securities of the Company during the aforesaid trading window closure period. The aforesaid information is also available on the website of the Company https://ilshospitals.com Kindly take the aforesaid information on record and oblige. Thanking You, Yours sincerely, For GPT Healthcare Limited Ankur Sharma Company Secretary and Compliance Officer M. No A31833